{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:53:34Z","timestamp":1790960014895,"version":"4.1.0"},"reference-count":63,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Pfizer Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"DOI":"10.1080\/14737167.2026.2737558","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:26:48Z","timestamp":1790749608000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and economic benefits of bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for prevention of RSV in adults: a cost-effectiveness analysis for Singapore"],"prefix":"10.1080","author":[{"given":"Karan","family":"Thakkar","sequence":"first","affiliation":[{"name":"Pfizer","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Shajarizadeh","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishu","family":"Gaind","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Ivkovic","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopika","family":"Balasubramanian","sequence":"additional","affiliation":[{"name":"Evidinno Outcomes Research","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rengina","family":"Kefalogianni","sequence":"additional","affiliation":[{"name":"Pfizer","place":["Tadworth, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pfizer","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Choong","family":"See","sequence":"additional","affiliation":[{"name":"National University Hospital","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Lay-Hoon","family":"Kwa","sequence":"additional","affiliation":[{"name":"Singapore General Hospital","place":["Singapore"]},{"name":"Duke-National University of Singapore Medical School","place":["Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Mendes","sequence":"additional","affiliation":[{"name":"Pfizer","place":["Tadworth, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"e_1_3_7_3_1","unstructured":"Communicable Diseases Agency Singapore [Internet]. Respiratory syncytial virus. 2025. Available from: https:\/\/www.cda.gov.sg\/professionals\/diseases\/respiratory-syncytial-virus\/"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820000400"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41030-025-00321-2"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00792-3"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa183"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/17460794.2024.2420474"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12730"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70098"},{"key":"e_1_3_7_11_1","unstructured":"Kumar A Trikha S Mehta M et al. Economic burden of respiratory syncytial virus (RSV) infection among older adults in select asia-pacific economic cooperation (APEC) countries [White paper]. 2024."},{"key":"e_1_3_7_12_1","unstructured":"Health Sciences Authority [Internet]. New drug indication approval. 2025 Jul. Available from: https:\/\/www.hsa.gov.sg\/announcements\/new-drug-indication-approvals\/new-drug-indication-approval"},{"key":"e_1_3_7_13_1","unstructured":"Health Sciences Authority [Internet]. New drug approvals. 2024. Available from Jul. Available from: https:\/\/www.hsa.gov.sg\/announcements\/new-drug-approval\/new-drug-approvals"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2024.2436183"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12111232"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.15245"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"e_1_3_7_18_1","unstructured":"Singapore Department of Statistics [Internet]. Singapore residents by age group ethnic group and sex at end June; 2025. Available from: https:\/\/tablebuilder.singstat.gov.sg\/table\/TS\/M810011"},{"key":"e_1_3_7_19_1","unstructured":"Singapore Department of Statistics [Internet]. Singapore residents by single year of age and sex at end June; 2025. Available from: https:\/\/tablebuilder.singstat.gov.sg\/table\/TS\/M810731"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae631.2508"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00904-z"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0105-2022"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106476"},{"key":"e_1_3_7_24_1","unstructured":"Singapore Department of Statistics [Internet]. Age-specific death rates; 2024. Available from: https:\/\/tablebuilder.singstat.gov.sg\/table\/TS\/M810141#"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2026.101520"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213836"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-014-0859-5"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2022.2134120"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.10.029"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12903"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac069"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.07.001"},{"key":"e_1_3_7_33_1","unstructured":"Singapore General Hospital [Internet]. Outpatient charges; 2024. Available from: https:\/\/www.sgh.com.sg\/patient-care\/visiting-specialist\/charges-payments-singapore-general-hospital"},{"key":"e_1_3_7_34_1","unstructured":"Ministry of Manpower [Internet]. Table: occupational wages. 2024. Available from: https:\/\/stats.mom.gov.sg\/Pages\/Occupational-Wages-Tables2024.aspx"},{"key":"e_1_3_7_35_1","unstructured":"Ministry of Manpower [Internet]. Section A: labour force status labour force profile labour force participation rate. 2025. Available from: https:\/\/stats.mom.gov.sg\/Pages\/mrsd-labour-force-in-singapore-advance-release-2025.aspx"},{"key":"e_1_3_7_36_1","unstructured":"Ministry of Manpower [Internet]. Section C: gross monthly income from employment. 2024. Available from: https:\/\/stats.mom.gov.sg\/Pages\/Labour-Force-In-Singapore-2024.aspx"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2010.131768"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2019.06.005"},{"key":"e_1_3_7_39_1","unstructured":"Ministry of Manpower [Internet]. Conditions of Employment 2022. 2023. Available from: https:\/\/stats.mom.gov.sg\/Pages\/Conditions-Of-Employment-2022.aspx"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18126277"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810396401"},{"key":"e_1_3_7_42_1","unstructured":"Agency for Care Effectiveness [Internet]. Drug evaluation methods and process guide. 2019. Available from: https:\/\/www.ace-hta.gov.sg\/docs\/default-source\/process-methods\/ace-methods-and-process-guide-for-drug-evaluation-(20-dec-2019).pdf"},{"key":"e_1_3_7_43_1","unstructured":"International Monetary Fund [Internet]. GDP per capita current prices U.S. dollars per capita. 2025. Available from: https:\/\/www.imf.org\/external\/datamapper\/NGDPDPC@WEO\/CHN\/HKG\/JPN\/KOR\/SGP\/TWN"},{"key":"e_1_3_7_44_1","unstructured":"World Health Organization [Internet]. Macroeconomics and health: investing in health for economic development: executive summary \/ report of the commission on macroeconomics and health Geneva. 2001 [cited 2024 Jun 4]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/42463\/a74868.pdf?sequence=1&isAllowed=y"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.15896"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69017-8"},{"key":"e_1_3_7_47_1","unstructured":"Ministry of Health Singapore [Internet]. Cost financing; 2023. Available from: https:\/\/www.moh.gov.sg\/managing-expenses\/bills-and-fee-benchmarks\/cost-financing\/"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101494"},{"key":"e_1_3_7_49_1","unstructured":"Agency for Care Effectiveness [Internet]. Drug and vaccine evaluation methods and process guide. 2023. Available from: https:\/\/isomer-user-content.by.gov.sg\/68\/f000a2dd-628b-42b1-8be3-0b512584155d\/drug-and-vaccine-evaluation-methods-and-process-guide-version-3-1-(september-2023).pdf"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70291"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.56767"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0160-2025"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103292"},{"key":"e_1_3_7_54_1","volume-title":"P273 using the vaccine probe approach to estimate RSV disease burden and RSV prefusion F protein\u2013based vaccine impact in Denmark","author":"Rudolph AE","year":"2026","unstructured":"Rudolph AE, Zhang P, Aliabadi N, Lassen M, editors, et al. P273 using the vaccine probe approach to estimate RSV disease burden and RSV prefusion F protein\u2013based vaccine impact in Denmark. Rome (IL): ReSViNET; 2026."},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.15405"},{"key":"e_1_3_7_56_1","doi-asserted-by":"crossref","unstructured":"Burkart K Liang C Rafferty Q et al. Global regional and national estimates of adult respiratory and cardiorespiratory hospitalisations attributable to respiratory syncytial virus from 2015 to 2022: application of the global burden of disease framework. Preprints Lancet. 2026.","DOI":"10.2139\/ssrn.6548590"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad658"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.02.041"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101605"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab118"},{"key":"e_1_3_7_61_1","unstructured":"Ministry of Health Singapore [Internet]. Take\u2011up and subsidy rates for vaccines listed in the national adult immunisation schedule. 2025. Available from: https:\/\/www.moh.gov.sg\/newsroom\/take-up-and-subsidy-rates-for-vaccines-listed-in-national-adult-immunisation-schedule\/"},{"key":"e_1_3_7_62_1","unstructured":"Ministry of Health Singapore [Internet]. National Adult Immunisation Schedule (NAIS). 2025. Available from: https:\/\/go.gov.sg\/nais-table"},{"key":"e_1_3_7_63_1","unstructured":"Communicable Diseases Agency Singapore. New vaccines against shingles and pneumococcal disease added to national adult immunisation schedule. 2025 Aug 29 [press release]."},{"key":"e_1_3_7_64_1","unstructured":"Ministry of Health Singapore [Internet]. Healthier SG vaccinations - under healthier SG vaccinations eligible Singapore citizens (SCs) and permanent residents (PRs) will receive subsidies for nationally recommended vaccinations while eligible SCs who are enrolled in healthier SG will enjoy special subsidies. 2025. Available from: https:\/\/www.moh.gov.sg\/managing-expenses\/schemes-and-subsidies\/healthier-sg-vaccinations\/"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2026.128285"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2737558","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14737167.2026.2737558","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737167.2026.2737558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:19:42Z","timestamp":1790957982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737167.2026.2737558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":63,"alternative-id":["10.1080\/14737167.2026.2737558"],"URL":"https:\/\/doi.org\/10.1080\/14737167.2026.2737558","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}